EN /

Research

My work spans foundation models for biological world simulation, medical imaging, computational chemistry, and clinical AI.

Publications Published / Under Review · 3 papers
Advanced Materials IF 27.4 · CAS Q1 Top Minor Revision Confidential

Heterojunction Nanozyme-doped Thermoresponsive Hydrogel for Synergistic ROS Scavenging and Microenvironment Remodeling in Osteoarthritis

et al., incl. Zhibin Wang (DFT computation)

A nanozyme-doped thermoresponsive hydrogel system with DFT-validated catalytic mechanism for osteoarthritis treatment. Combines computational chemistry with experimental validation for synergistic ROS scavenging and microenvironment remodeling.

Details available after publication
Planned / In Progress 2 papers
Cyborg and Bionic Systems IF 18.1 · CAS Q1 Top · Target Journal In Preparation · 1st Author Planned TCM-Quartet

A Multimodal Agent for the Four Diagnostic Methods of Traditional Chinese Medicine: Inspection, Auscultation, Inquiry, and Palpation

Zhibin Wang1, [Collaborators], [Longhua Hospital Attending], [Shanghai Univ. of TCM]

1st Author · Exclusive clinical dataset from Longhua Hospital, Shanghai Univ. of TCM · Target acceptance March 2027

The first end-to-end multimodal agent that treats the four diagnostic methods of traditional Chinese medicine (inspection, auscultation, inquiry, palpation) as unified inputs to a single clinical decision support system. Built on an exclusive clinical dataset from Longhua Hospital, with a vision–language–time-series fusion architecture for end-to-end syndrome differentiation and prescription suggestion.

Research Plan

  • First end-to-end multimodal model treating tongue imaging + auscultation audio + chief complaint text + pulse-wave time series as unified inputs
  • Built on an exclusive clinical dataset from Longhua Hospital — all four channels collected from real outpatient visits
  • Joint annotation with attending physicians at a Class-A TCM hospital, establishing the first open benchmark for TCM syndrome differentiation
  • Targeting Cyborg and Bionic Systems (IF 18.1, CAS Q1 Top)
  • Research line led by an attending physician at Longhua (UCL visiting scholar); first-authored
CA: A Cancer Journal for Clinicians IF ~500+ · Highest IF in oncology In Preparation · Co-First Author Planned OsteoEpi

Global Epidemiology and Clinical Decision Pathways for Bone Tumors: A Multi-Center Evidence Synthesis

[Co-first ×N], Zhibin Wang, [Other authors], Mingyang Jiang* (NUS)

Co-First Author (later in the order) · With Dr. Mingyang Jiang, NUS Yong Loo Lin School of Medicine · Target submission Summer 2026

CA: A Cancer Journal for Clinicians (IF ~500+) is the highest-impact medical journal in the world. This review systematically integrates global bone tumor epidemiology with multi-center clinical decision pathways, building a cross-region, cross-age, cross-subtype framework for clinical decision-making. The work draws on a multi-center bone-sarcoma imaging and pathology platform jointly built by 6 Class-A hospitals.

Research Plan

  • Led by Dr. Mingyang Jiang at NUS Yong Loo Lin School of Medicine; contributing as co-first author on writing and data synthesis
  • Integrates multi-center bone-sarcoma imaging, pathology, and follow-up data from 6 Class-A hospitals
  • Builds a global epidemiological portrait of bone tumors across regions, ages, and histologic subtypes
  • Targeting CA: A Cancer Journal for Clinicians (IF ~500+, highest-impact medical journal in the world)
  • Submission planned for summer 2026; expected acceptance November 2026
Research Interests

Biological World Simulation

Foundation models for tumor immune microenvironment dynamics and counterfactual trajectory prediction.

Medical Imaging

Spatiotemporal transformers and graph neural networks for tumor segmentation in DCE-MRI.

Computational Chemistry

DFT-based validation of catalytic mechanisms in nanomaterial-based therapeutic systems.

Clinical AI

Bridging computational methods and clinical practice for translational biomedical research.